http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3626067-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e70c0aeade92d7571d955d3b90ea06e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-28
filingDate 1965-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1971-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6107242e95d119161c5628023c6c47f2
publicationDate 1971-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3626067-A
titleOfInvention Substituted oxazolines, useful as pharmaceuticals
abstract 1. A compound of the formula R1 is phenyl, 2-thienyl, 3-thienyl, 2-furanyl or 3-furanyl; R2 is methyl, ethyl, or cyclopropyl; A, X, D and Z are each separately hydrogen or alkyl of one through four carbon atoms with the limitation that the total number of carbon atoms added together in A, X, D and Z is less than nine. 14. A pharmaceutical composition containing an inert pharmacological diluent and a pharmacologically active amount of a compound of the formula R1 is phenyl, 2-thienyl, 3-thienyl, 2-furanyl or 3-furanyl; R2 is methyl, ethyl, or cyclopropyl; A, X, D and Z are each separately hydrogen or alkyl of one through four carbon atoms with the limitation that the total number of carbon atoms added together in A, X, D and Z is less than nine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3988464-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4102890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5325565-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2212143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4267345-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5686477-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2070923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S584715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4315020-A
priorityDate 1965-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2027031-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2870160-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457798390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414879003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415726232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415878325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422599927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420223184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457798372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID215268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705

Total number of triples: 50.